直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments - September 2015

September 02, 2015

Authored and Edited by Elizabeth D. Ferrill

Spotlight on Upcoming Oral Arguments – July 2015

Poly-America v. API Industries, No. 15-1248 - Courtroom 402

In granting summary judgment of noninfringement, the district court relied on an expert opinion that API’s accused products and Poly-America’s patented design are not substantially similar under the ordinary-observer test. This appeal asks the Federal Circuit to determine whether experts can opine on what ordinary observers would perceived under FRE 701, and whether testimony identifying only theoretical uses of the accused products, not actual or frequent occurrences, is sufficient to warrant summary judgment.

 Wednesday September 9, 2015

 Ergowerx v. Maxell Corp. of America, No. 14-1641 - Courtroom 402

Under Mallinckrodt v. Medipart, 976 F.2d 700 (Fed. Cir. 1992), a sale does not exhaust the patentee’s rights when it is unauthorized or violates contractual conditions imposed by the seller. In this appeal, the parties debate whether Mallinckrodt’s conditional-sale doctrine remains good law after the Supreme Court’s Quanta decision. This question is currently before the en banc court in Lexmark International v. Impression Products, which will be argued in October.

Thursday September 10, 2015

Belden Inc. v. Berk-Tek LLC, No. 14-1575 - Courtroom 402

In this appeal, the IPR petitioner submitted an expert declaration in response to the patent owner’s preliminary response and accompanying expert declaration. The patent owner challenges the admittance of the petitioner’s declaration, arguing that petitioners should be required to produce all evidence in the initial petition. The PTO has intervened in this case.

Ethicon Endo-Surgery v. Covidien, No. 14-1771 - Courtroom 402

In another appeal involving IPR practice at the PTAB, the patent owner argues that the institution decision and the final decision in an IPR should be made by different decision makers, and not the same PTAB panel. It argues that the statute requires divided decision-making, such that the Director of the PTO makes the institution decision, and a PTAB panel makes the final decision. The PTO has intervened in this case.

Friday September 11, 2015

MCM Portfolio v. Hewlett-Packard, No. 15-1091 - Courtroom 201

In this case, MCM Portfolio argues that the IPR practice at the PTAB is unconstitutional for violating the 7th Amendment right to a jury trial. The PTO has intervened in this case.

Tags

Spotlight on Upcoming Oral Arguments

Contacts

Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

INCONTESTABLE® Blog

Netflix Prevails in Copyright Infringement Suit Regarding Tiger King

May 14, 2026

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP